Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
Hum Vaccin Immunother
; 10(10): 2853-63, 2014.
Article
em En
| MEDLINE
| ID: mdl-25483647
Palavras-chave
ADE, antibody-dependent enhancement; AE, adverse event; ALT, aspartate aminotransferase; AST, alanine aminotransferase; CBA, cytometric bead array; CI, confidence interval; CPK, creatine phosphokinase; CYD-TDV, CYD tetravalent dengue vaccine; GMT, geometric mean titres; ICS, intracellular cytokine staining; IFN, interferon; JE, Japanese encephalitis; Japanese encephalitis; LLOQ, lower limit of quantitation; MOI, multiplicity of infection; MedDRA, medical dictionary for regulatory activities; PBMC, peripheral blood mononuclear cells; PFU, plaque forming unit; PRNT, plaque reduction neutralization test; RT-PCR, reverse transcriptase-polymerase chain reaction; TCID, tissue culture infectious dose; VDV, vero-cell adapted attenuated dengue vaccine; YF, yellow fever; dengue; flavivirus; immunogenicity; safety; vaccine
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Viremia
/
Dengue
/
Vírus da Dengue
/
Vacinas contra Dengue
/
Anticorpos Antivirais
Tipo de estudo:
Clinical_trials
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
País/Região como assunto:
Mexico
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article